86 patents currently held
11 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Aug 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
6
Ending by 2030
Aug 2027
Next term end
49
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends May 2035 · High confidence
Also notable
Ends Aug 2034 · High confidence
Also notable
Ends Jan 2032 · High confidence
De Novo Synthesized Gene Libraries
US 11,559,778
Cited by 49 later US patents, top 1% of utility patents granted in 2023 in our data. Protection runs to 2035.
De Novo Synthesized Gene Libraries
US 11,452,980
Cited by 43 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
Methods and Devices for Nucleic Acid Synthesis
US 9,295,965
Cited by 174 later US patents, top 5% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Formerly held, still cited
Notable
Ends Oct 2037 · High confidence
Cited by 38 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2037.
now held by Atlas Data Storage, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 4, 2026The maintenance fee for Methods for Screening Proteins Using DNA Encoded Chemical Libraries as Templates for Enzyme Catalysis (US 10,308,931) comes due Dec 4, 2026. Unpaid by Jun 4, 2027, it lapses early.
- 2 fees due Jan 4 to 11, 2027 · next Jan 4
- 3 fees due Feb 20 to 22, 2027 · next Feb 20
- 3 fees due Apr 6 to 29, 2027 · next Apr 6
- 2 fees due May 7 to 17, 2027 · next May 7
- 2 fees due Jun 19 to 22, 2027 · next Jun 19
- 2 fees due Sep 10 to 29, 2027 · next Sep 10
- 3 fees due Oct 14 to 30, 2027 · next Oct 14
- 1 fee due Nov 5, 2027The maintenance fee for De Novo Synthesized Gene Libraries (US 10,639,609) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.
Recent changes
- Oct 13Assignment recorded on 1 record: Hoglund, Bryan N. and 5 others to Twist Bioscience Corporation Recorded Oct 13, 2026, executed Jul 11, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76359, frame 703.
- 2 of the patents on this record were granted since Aug 17, 2026
- 2 terms have ended since Aug 17, 2026
What they patent
The 5 largest of its 49 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| De Novo Synthesized Gene Libraries (2015) | 11 in force | to May 2035 |
| De Novo Synthesized Gene Libraries (2014) | 6 in force | to May 2035 |
| Polynucleotides, Reagents, and Methods for Nucleic Acid Hybridization | 3 in force | to May 2041 |
| Methods and Compositions for Rapid Nucleic Acid Library Preparation | 3 in force | to Nov 2038 |
| Methods for Seamless Nucleic Acid Assembly | 3 in force | to Jun 2038 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,202,608 | Iterative Nucleic Acid Assembly Using Activation of Vector-Encoded Traits In force · Low confidence | In force | Low confidence | |
| US 8,053,191 | Iterative Nucleic Acid Assembly Using Activation of Vector-Encoded Traits In force · High confidence | In force | High confidence | |
| US 10,207,240 | Methods and Microfluidic Devices for the Manipulation of Droplets in High Fidelity Polynucleotide Assembly In force · High confidence | In force | High confidence | |
| US 9,216,414 | Microfluidic Devices and Methods for Gene Synthesis In force · High confidence | In force | High confidence | |
| US 9,422,600 | Methods and Apparatuses for Chip-Based DNA Error Reduction In force · Medium confidence | In force | Medium confidence | |
| US 10,829,759 | Methods and Apparatuses for Chip-Based DNA Error Reduction In force · Low confidence | In force | Low confidence | |
| US 11,845,054 | Methods and Devices for Nucleic Acids Synthesis In force · Low confidence | In force | Low confidence | |
| US 9,187,777 | Methods and Devices for In Situ Nucleic Acid Synthesis In force · High confidence | In force | High confidence | |
| US 11,071,963 | Assembly of High Fidelity Polynucleotides In force (reinstated) · Medium confidence | In force (reinstated) | Medium confidence | |
| US 9,295,965 | Methods and Devices for Nucleic Acid Synthesis In force · High confidence | In force | High confidence |
Also on record, not counted in the 86: 11 patents in force now held by others · 10 patents ended · 57 applications pending · 34 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.